Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: May 5, 2021
Total Value: $268M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRD | OCUPHIRE PHARMA INC | 2,068,530 | $13.43M | 5.0% | $6.91 | 0.0% | COM | 67577R102 |
| — | CURIS INC | 822,009 | $6.732M | 2.5% | $8.19 | — | COM NEW | 231269200 |
| OCUL | OCULAR THERAPEUTIX INC | 303,174 | $6.276M | 2.3% | $14.85 | 0.0% | COM | 67576A100 |
| — | IVERIC BIO INC | 902,633 | $6.237M | 2.3% | $6.91 | — | COM | 46583P102 |
| — | SUTRO BIOPHARMA INC | 276,719 | $6.008M | 2.2% | $21.71 | — | COM | 869367102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 263,596 | $5.862M | 2.2% | $20.74 | 0.0% | COM | 87164F105 |
| — | GENPREX INC | 1,409,785 | $5.851M | 2.2% | $4.15 | — | COM | 372446104 |
| — | VERASTEM INC | 2,731,974 | $5.819M | 2.2% | $2.13 | — | COM | 92337C104 |
| ANAB | ANAPTYSBIO INC | 261,209 | $5.616M | 2.1% | $24.28 | 0.0% | COM | 032724106 |
| — | BELLUS HEALTH INC NEW | 1,682,535 | $5.149M | 1.9% | $3.06 | — | COM NEW | 07987C204 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 361,930 | $5.107M | 1.9% | $13.93 | 0.0% | COM | 22663K107 |
| INSM | INSMED INC | 148,743 | $4.952M | 1.8% | $36.53 | 0.0% | COM PAR $.01 | 457669307 |
| — | INTRA CELLULAR THERAPIES INC | 153,348 | $4.876M | 1.8% | $31.80 | — | COM | 46116X101 |
| COGT | COGENT BIOSCIENCES INC | 432,563 | $4.858M | 1.8% | $10.99 | 0.0% | COM | 19240Q201 |
| IMTX | IMMATICS N.V. | 405,670 | $4.377M | 1.6% | $10.55 | 0.0% | SHS | N44445109 |
| — | ARYA SCIENCES ACQUISITION CO | 400,000 | $4.34M | 1.6% | $10.85 | — | COM CL A | G3166W106 |
| MYGN | MYRIAD GENETICS INC | 218,650 | $4.324M | 1.6% | $16.15 | 0.0% | COM | 62855J104 |
| — | EUCRATES BIOMEDICAL ACQU COR | 400,000 | $4.264M | 1.6% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 239,520 | $4.196M | 1.6% | $18.00 | 0.0% | COM NEW | 15117B202 |
| CSTL | CASTLE BIOSCIENCES INC | 61,991 | $4.163M | 1.6% | $54.21 | 0.0% | COM | 14843C105 |
| ILMN | ILLUMINA INC | 11,200 | $4.144M | 1.5% | $318.77 | 0.0% | COM | 452327109 |
| PODD | INSULET CORP | 16,200 | $4.141M | 1.5% | $248.10 | 0.0% | COM | 45784P101 |
| AUPH | AURINIA PHARMACEUTICALS INC | 293,917 | $4.065M | 1.5% | $14.55 | 0.0% | COM | 05156V102 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 388,845 | $3.966M | 1.5% | $10.20 | — | COM | 15957T107 |
| — | CONSTELLATION PHARMCETICLS I | 134,233 | $3.866M | 1.4% | $28.80 | — | COM | 210373106 |
| CHRS | COHERUS BIOSCIENCES INC | 216,925 | $3.77M | 1.4% | $17.80 | 0.0% | COM | 19249H103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 185,854 | $3.747M | 1.4% | $21.52 | 0.0% | COM | 74366E102 |
| IMUX | IMMUNIC INC | 244,155 | $3.733M | 1.4% | $17.96 | 0.0% | COM | 4525EP101 |
| IMVT | IMMUNOVANT INC | 77,622 | $3.585M | 1.3% | $46.23 | 0.0% | COM | 45258J102 |
| LNTH | LANTHEUS HLDGS INC | 262,465 | $3.541M | 1.3% | $13.09 | 0.0% | COM | 516544103 |
| CRDF | CARDIFF ONCOLOGY INC | 185,552 | $3.338M | 1.2% | $17.58 | 0.0% | COM | 14147L108 |
| — | CHINOOK THERAPEUTICS INC | 205,799 | $3.264M | 1.2% | $15.86 | — | COM | 16961L106 |
| TIOG | MICT INC | 1,533,425 | $3.19M | 1.2% | $2.23 | 0.0% | COM | 55328R109 |
| — | VINCERA PHARMA INC | 150,150 | $3.14M | 1.2% | $20.91 | — | COM | 92731L106 |
| — | AVADEL PHARMACEUTICALS PLC | 465,589 | $3.11M | 1.2% | $6.68 | — | SPONSORED ADR | 05337M104 |
| HAE | HAEMONETICS CORP | 26,144 | $3.105M | 1.2% | $107.66 | 0.0% | COM | 405024100 |
| SCYX | SCYNEXIS INC | 400,000 | $3.06M | 1.1% | $5.86 | 0.0% | COM NEW | 811292200 |
| — | ORBITAL ENERGY GROUP INC | 1,353,995 | $2.965M | 1.1% | $2.19 | — | COM | 68559A109 |
| — | SIENTRA INC | 752,634 | $2.928M | 1.1% | $3.89 | — | COM | 82621J105 |
| — | ALPHA HEALTHCARE ACQUISTN CO | 275,000 | $2.907M | 1.1% | $10.57 | — | UNIT 09/21/2027 | 020751202 |
| MLTX | HELIX ACQUISITION CORP | 250,000 | $2.843M | 1.1% | $11.37 | — | COM CL A | G4444C102 |
| NNDM | NANO DIMENSION LTD | 304,600 | $2.772M | 1.0% | $9.10 | — | SPONSORD ADS NEW | 63008G203 |
| — | LIFESCI ACQUISITION II CORP | 250,000 | $2.668M | 1.0% | $10.67 | — | COM | 53229E103 |
| — | CONSONANCE HFW ACQUISITION C | 250,000 | $2.618M | 1.0% | $10.47 | — | UNIT 99/99/9999 | G2445M129 |
| — | TURMERIC ACQUISITION CORP | 254,000 | $2.609M | 1.0% | $10.27 | — | UNIT 10/08/2025 | G9127T116 |
| — | FS DEV CORP | 234,000 | $2.574M | 1.0% | $11.00 | — | COM CL A | 303020101 |
| — | EIGER BIOPHARMACEUTICALS INC | 197,500 | $2.427M | 0.9% | $12.29 | — | COM | 28249U105 |
| — | SARISSA CAPITAL ACQUISITN CO | 225,000 | $2.396M | 0.9% | $10.65 | — | UNIT 10/23/2027 | G7823W128 |
| — | CM LIFE SCIENCES INC | 200,000 | $2.32M | 0.9% | $11.60 | — | UNIT 09/01/2025 | 18978W208 |
| — | TCR2 THERAPEUTICS INC | 73,991 | $2.289M | 0.9% | $30.94 | — | COM | 87808K106 |
| — | INTERSECT ENT INC | 99,661 | $2.282M | 0.9% | $22.90 | — | COM | 46071F103 |
| — | TIZIANA LIFE SCIENCES PLC | 1,077,883 | $2.177M | 0.8% | $2.02 | — | SPONSORED ADS | 88875G101 |
| — | AEGLEA BIOTHERAPEUTICS INC | 267,753 | $2.107M | 0.8% | $7.87 | — | COM | 00773J103 |
| — | ESSA PHARMA INC | 175,067 | $2.089M | 0.8% | $11.93 | — | COM NEW | 29668H708 |
| TVTX | TRAVERE THERAPEUTICS INC | 76,484 | $2.085M | 0.8% | $23.35 | 0.0% | COM | 89422G107 |
| — | KARYOPHARM THERAPEUTICS INC | 133,951 | $2.074M | 0.8% | $15.48 | — | COM | 48576U106 |
| — | JIYA ACQUISITION CORP | 200,000 | $2.06M | 0.8% | $10.30 | — | COM CL A | 47760M102 |
| GMED | GLOBUS MED INC | 31,512 | $2.055M | 0.8% | $57.49 | 0.0% | CL A | 379577208 |
| DXCM | DEXCOM INC | 5,500 | $2.033M | 0.8% | $89.29 | 0.0% | COM | 252131107 |
| — | ONCTERNAL THERAPEUTICS INC | 411,667 | $2.017M | 0.8% | $4.90 | — | COM | 68236P107 |
| — | RIGEL PHARMACEUTICALS INC | 571,026 | $1.999M | 0.7% | $3.50 | — | COM NEW | 766559603 |
| ICUI | ICU MED INC | 9,321 | $1.999M | 0.7% | $193.98 | 0.0% | COM | 44930G107 |
| LRMR | LARIMAR THERAPEUTICS INC | 93,261 | $1.997M | 0.7% | $20.04 | 0.0% | COM | 517125100 |
| — | CATALYST BIOSCIENCES INC | 313,745 | $1.98M | 0.7% | $6.31 | — | COM NEW | 14888D208 |
| — | OTONOMY INC | 299,890 | $1.94M | 0.7% | $6.47 | — | COM | 68906L105 |
| — | OPTINOSE INC | 458,589 | $1.899M | 0.7% | $4.14 | — | COM | 68404V100 |
| — | CTI BIOPHARMA CORP | 588,992 | $1.897M | 0.7% | $3.22 | — | COM | 12648L601 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 250,000 | $1.863M | 0.7% | $5.16 | 0.0% | COM | 09058V103 |
| — | OPENDOOR TECHNOLOGIES INC | 240,000 | $1.853M | 0.7% | $7.72 | — | *W EXP 12/18/202 | 683712111 |
| CTMX | CYTOMX THERAPEUTICS INC | 273,703 | $1.793M | 0.7% | $7.14 | 0.0% | COM | 23284F105 |
| — | CELLECTAR BIOSCIENCES INC | 851,852 | $1.772M | 0.7% | $2.08 | — | COM PAR | 15117F500 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 62,962 | $1.771M | 0.7% | $24.49 | 0.0% | COM | 03969K108 |
| — | HARPOON THERAPEUTICS INC | 101,994 | $1.694M | 0.6% | $16.61 | — | COM | 41358P106 |
| — | SWITCHBACK ENERGY ACQUISTN C | 105,000 | $1.619M | 0.6% | $15.42 | — | *W EXP 07/25/202 | 87105M110 |
| — | EPIZYME INC | 130,000 | $1.412M | 0.5% | $10.86 | — | COM | 29428V104 |
| — | BCTG ACQUISITION CORP | 120,000 | $1.373M | 0.5% | $11.44 | — | COM | 05492W103 |
| ATYR | ATYR PHARMA INC | 332,258 | $1.289M | 0.5% | $3.66 | 0.0% | COM NEW | 002120202 |
| — | VERRICA PHARMACEUTICALS INC | 108,794 | $1.252M | 0.5% | $11.51 | — | COM | 92511W108 |
| — | BCLS ACQUISITION CORP | 100,000 | $1.114M | 0.4% | $11.14 | — | COM CL A | G0904B105 |
| — | 9 METERS BIOPHARMA INC | 1,264,994 | $1.087M | 0.4% | $0.86 | — | COM | 654405109 |
| — | ROTH CH ACQUISITION II CO | 100,000 | $1.04M | 0.4% | $10.40 | — | UNIT 12/11/2025 | 778673202 |
| — | CNS PHARMACEUTICALS INC | 534,148 | $951K | 0.4% | $1.78 | — | COM | 18978H102 |
| — | FAT BRANDS INC | 300,000 | $810K | 0.3% | $2.70 | — | *W EXP 06/30/202 | 30258N121 |
| — | VINCERA PHARMA INC | 215,250 | $710K | 0.3% | $3.30 | — | *W EXP 12/24/202 | 92731L114 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 500,000 | $495K | 0.2% | $0.99 | — | *W EXP 03/05/202 | 15957T115 |
| — | CEREVEL THERAPEUTICS HLDNG I | 64,666 | $365K | 0.1% | $5.64 | — | *W EXP 06/09/202 | 15678U102 |
| — | IMMATICS N.V. | 97,467 | $281K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| KBNT | KUBIENT INC | 42,269 | $236K | 0.1% | $4.13 | 0.0% | COM | 50116V107 |
| — | AMPLITUDE HLTHCRE AQUSTIN CO | 162,500 | $236K | 0.1% | $1.45 | — | *W EXP 12/01/202 | 03212A113 |
| SHPSQ | GALILEO ACQUISITION CORP | 200,000 | $168K | 0.1% | $0.84 | — | *W EXP 10/31/202 | G3770A110 |
| — | VENUS CONCEPT INC | 93,643 | $162K | 0.1% | $1.73 | — | COM | 92332W105 |
| — | QUOTIENT LTD | 24,912 | $130K | 0.0% | $5.22 | — | SHS | G73268107 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $128K | 0.0% | $12.80 | — | ORD SHS | G4411D109 |
| — | LYRA THERAPEUTICS INC | 5,218 | $59,000 | 0.0% | $11.31 | — | COM | 55234L105 |